These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 8931165

  • 1. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB, Williamson DJ, Cowen PJ.
    Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
    [Abstract] [Full Text] [Related]

  • 2. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 3. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.
    Fineberg NA, Roberts A, Montgomery SA, Cowen PJ.
    Br J Psychiatry; 1997 Sep; 171():280-2. PubMed ID: 9337985
    [Abstract] [Full Text] [Related]

  • 4. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT, Porter RJ, Joyce PR.
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [Abstract] [Full Text] [Related]

  • 5. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 6. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 7. State and trait abnormalities in serotonin function in major depression.
    Bhagwagar Z, Whale R, Cowen PJ.
    Br J Psychiatry; 2002 Jan; 180():24-8. PubMed ID: 11772847
    [Abstract] [Full Text] [Related]

  • 8. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S.
    Life Sci; 1984 Mar 12; 34(11):1029-39. PubMed ID: 6700367
    [Abstract] [Full Text] [Related]

  • 9. Blunted prolactin response to D-fenfluramine in post-stroke major depression.
    Morris P, Hopwood M, Maguire K, Norman T, Schweitzer I.
    J Affect Disord; 2003 Sep 12; 76(1-3):273-8. PubMed ID: 12943959
    [Abstract] [Full Text] [Related]

  • 10. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P, Brambilla F, Bortolotti F, Ferraro C, Maj M.
    Psychol Med; 1998 Jul 12; 28(4):975-83. PubMed ID: 9723152
    [Abstract] [Full Text] [Related]

  • 11. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B.
    Int Psychogeriatr; 1996 Jul 12; 8(1):83-102. PubMed ID: 8805090
    [Abstract] [Full Text] [Related]

  • 12. D-fenfluramine challenge in posttraumatic stress disorder.
    Davis LL, Clark DM, Kramer GL, Moeller FG, Petty F.
    Biol Psychiatry; 1999 Apr 01; 45(7):928-30. PubMed ID: 10202582
    [Abstract] [Full Text] [Related]

  • 13. Future suicide attempt and responses to serotonergic challenge.
    Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ.
    Neuropsychopharmacology; 2010 Apr 01; 35(5):1063-72. PubMed ID: 18354392
    [Abstract] [Full Text] [Related]

  • 14. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V, McLoughlin D, Dinan TG.
    J Affect Disord; 1992 Nov 01; 26(3):143-50. PubMed ID: 1460163
    [Abstract] [Full Text] [Related]

  • 15. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P, La Rocca A, Fuschino A, Bortolotti F, Maj M.
    Psychoneuroendocrinology; 1999 Feb 01; 24(2):201-8. PubMed ID: 10101728
    [Abstract] [Full Text] [Related]

  • 16. Prolactin response to D-fenfluramine in outpatients with major depression.
    Kavoussi RJ, Kramer J, Hauger RL, Coccaro EF.
    Psychiatry Res; 1998 Jul 13; 79(3):199-205. PubMed ID: 9704866
    [Abstract] [Full Text] [Related]

  • 17. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug 13; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 18. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL.
    Neuropsychopharmacology; 1996 Dec 13; 15(6):595-607. PubMed ID: 8946434
    [Abstract] [Full Text] [Related]

  • 19. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Dec 13; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 20. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH, Rue J, Odontiadis J, Cowen PJ.
    Psychopharmacology (Berl); 1998 Mar 13; 136(2):198-200. PubMed ID: 9551777
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.